EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Impact of long-term medication on estrobolome-associated β-glucuronidase and sulfatase activities: Implications for estrogen homeostasis in postmenopausal women

María Elena Martínez-Nortes, Concepción Carrascosa-Romero, María Ángeles Ávila-Gálvez, Juan Carlos Espín

Maturitas · 2026-03 · 206 · 108830

DOI: 10.1016/j.maturitas.2026.108830 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Maturitas, 2026-03. Verfasst von María Elena Martínez-Nortes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Virgen de la Arrixaca University Hospital, Murcia, 30120, Spain. Hauptthemen laut MEDLINE: Sulfatases, Estrogens, Glucuronidase, Postmenopause. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, European Regional Development Fund, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menopause leads to a decline in circulating estrogen levels, increasing cardiometabolic risk, contributing to bone loss, and decreasing quality of life. The estrobolome, a subset of microbes with β-glucuronidase (GUS) and sulfatase activities, regulates estrogen homeostasis through deconjugation and enterohepatic recycling, thereby influencing systemic estrogen availability. Common long-term pharmacological treatments in postmenopausal women may alter gut microbial composition and function, potentially affecting estrobolome activity and systemic estrogen levels. This narrative review examines current evidence on how long-term pharmacological treatments may affect estrobolome-associated GUS and sulfatase activities, with implications for estrogen metabolism and health outcomes in postmenopausal women. A targeted literature search was performed to identify clinical studies on commonly prescribed drugs for hypertension, diabetes, dyslipidemia, osteoporosis, and depression in postmenopausal women, focusing on microbial taxa with reported GUS or sulfatase activity. Among the evaluated pharmacological classes, antidiabetic drugs, particularly metformin, are the most extensively studied, followed by antidepressants. These treatments can modulate key gut bacterial genera with GUS and sulfatase activities, including Bifidobacterium, Roseburia, Faecalibacterium, and Clostridium, which are relevant to metabolic and estrogen homeostasis. However, no studies have directly assessed the impact of pharmacological treatments on GUS and sulfatase activity in postmenopausal women. Understanding how chronic medication influences estrobolome dynamics may help identify strategies to support estrogen balance and improve systemic metabolic, hormonal, vascular, and inflammatory profiles. This review highlights the interplay between long-term medication, gut microbiota, and estrogen homeostasis as a promising avenue for personalized microbiota-targeted therapies in postmenopausal health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfatasesEstrogensGlucuronidasePostmenopauseGastrointestinal MicrobiomeHypoglycemic AgentsHumansFemaleHomeostasisAntidepressive AgentsBacteria

Stichwörter der Autor:innen

EstrobolomeGut microbiotaLong-term medicationMenopauseSulfataseβ-Glucuronidase

Substanzen

SulfatasesEstrogensGlucuronidaseHypoglycemic AgentsAntidepressive Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Virgen de la Arrixaca University Hospital, Murcia, 30120, Spain.
  • Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Campus Universitario de Espinardo, Murcia, 30100, Spain. Electronic address: mavila@cebas.csic.es.
  • Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Campus Universitario de Espinardo, Murcia, 30100, Spain. Electronic address: jcespin@cebas.csic.es.

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • European Regional Development Fund
  • European Commission
  • Comunidad Autónoma de la Región de Murcia
  • Fundación Séneca

Zitieren

APA

Martínez-Nortes, M. E., Carrascosa-Romero, C., Ávila-Gálvez, M. Á., & Espín, J. C. (2026). Impact of long-term medication on estrobolome-associated β-glucuronidase and sulfatase activities: Implications for estrogen homeostasis in postmenopausal women. Maturitas, 206, 108830. https://doi.org/10.1016/j.maturitas.2026.108830

Vancouver

Martínez-Nortes ME, Carrascosa-Romero C, Ávila-Gálvez MÁ, Espín JC. Impact of long-term medication on estrobolome-associated β-glucuronidase and sulfatase activities: Implications for estrogen homeostasis in postmenopausal women. Maturitas. 2026;206:108830. doi:10.1016/j.maturitas.2026.108830

BibTeX
@article{MartnezNortes2026,
  author = {Martínez-Nortes, María Elena and Carrascosa-Romero, Concepción and Ávila-Gálvez, María Ángeles and Espín, Juan Carlos},
  title = {Impact of long-term medication on estrobolome-associated β-glucuronidase and sulfatase activities: Implications for estrogen homeostasis in postmenopausal women},
  journal = {Maturitas},
  year = {2026},
  volume = {206},
  pages = {108830},
  doi = {10.1016/j.maturitas.2026.108830}
}
Kostenlos starten →